NL-OMON44301已完成不适用
ovel mass spectrometric monitoring (steroid metabolomics) to detect treatment success and chronic over- or under-treatment in children with CAH (CAH metabolomics). - Novel CAH monitoring tools
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 2 至 17（—）
入选标准
- •The subjects must have a genetically confirmed diagnosis of classical CAH (salt-losing or simple virilising) and
- •- group 1: being pre-pubertal and Tanner stage 1
- •- group 2: being late-pubertal and Tanner stage 3 plus or post-menarche
- •The subjects must personally provide, or have a legal guardian provide, written informed consent to participate in the trial, according to local regulations.
排除标准
- •- Intercurrent illnesses at or within one week before visit.
- •- Poor understanding of language by subjects and/or legal guardians, leading to insufficient ability to understand the written study information form.
研究者
相似试验
已完成
不适用
Establishment of mass spectrometric determination of drugs in hair and its application to forensic medicine and pharmacokinetic analysisDrug abuseJPRN-UMIN000013312Osaka Medical College5
已完成
不适用
Evaluation and Validation of New Biomarkers by Mass SpectrometryDiabetes MellitusNCT01025973Université de Sherbrooke99
招募中
不适用
Screening and Therapeutic Monitoring of Multiple Myeloma by MALDI-TOF MS AnalysisMonoclonal GammopathiesM-proteinMultiple MyelomaNCT05686447Zhujiang Hospital200
招募中
不适用
Comparative longitudinal mass spectrometry analysis of gingival crevicular fluid after traumatic dental Luxation injuriesroot resorptionDRKS00023448Poliklinik für Präventive Zahnmedizin, Parodontologie und Kariologie50
招募中
不适用
Determining Paediatric Usual Values for Hormones Dosages by LC-MS/MSControl ConditionNCT06694415Assistance Publique - Hôpitaux de Paris1,500